NCT00002341已完成不适用
An Open-Label Extension Study of Maintenance Therapy in HIV-Positive Subjects With Fluconazole-Refractory Oropharyngeal Candidiasis Who Have Responded to Itraconazole Oral Solution
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Janssen, LP
- 试验地点
- 2
研究概览
简要总结
To provide maintenance treatment with itraconazole solution for patients who were clinical responders in the ITR-USA-94 protocol, even if they subsequently relapsed.
详细描述
Patients who responded to therapy on protocol FDA 236B receive maintenance with itraconazole oral solution for up to 6 months.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)Familial Amyloid PolyneuropathyTTRTransthyretinFAPAmyloidosisNCT02175004Ionis Pharmaceuticals, Inc.135
已完成
3 期
Open-Label Treatment Extension of Protocol MNTX 301Terminal IllnessNCT01367600Bausch Health Americas, Inc.27
已完成
3 期
Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012Rheumatoid ArthritisNCT00356590Amgen468
已完成
3 期
Open-label Treatment in Cushing's SyndromeCushing DiseaseCushing SyndromeNCT03621280Cortendo AB51
No Longer Available
不适用
Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 TrialSolid TumorsNCT02354612Tracon Pharmaceuticals Inc.